SLC22A6 and pyelonephritis: The magnitude of IL-1β-driven OAT1/3 downregulation at 0.1 ng/mL (Figures 2 and 3) agrees quantitatively, in terms of directionality and magnitude expected for a reduction in basal uptake, with what we observed in vivo during active pyelonephritis (16).